Skip header and navigation

27 records – page 1 of 3.

Document Type
Evidence Search Report
Review Code
EOC111201-01 ESR
Question Submitted
November 12, 2020
Date Completed
November 23, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC111201-01 ESR
Question Submitted
November 12, 2020
Date Completed
November 23, 2020
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Subject
Treatment
Population
All
Priority Level
Level 4 Three weeks (21 days)
Cite As
Mueller, M; Young, C. Are probiotics effective for prevention or therapy of respiratory tract infections in all ages? 2020 Nov 23; Document no.: EOC111201-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 7 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC111201 RR
Question Submitted
November 12, 2020
Date Completed
November 25, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC111201 RR
Question Submitted
November 12, 2020
Date Completed
November 25, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Systematic reviews with pooled analysis found a statistical difference between probiotic and placebo groups in days of respiratory tract illness, number of antibiotic prescriptions and days of missed work/school · The evidence for the use of probiotics while statistically significant, is of low quality with high levels of heterogeneity · No significant difference in SAEs between groups, side effects of probiotic use mainly mild GI symptoms
Category
Clinical Management
Subject
Treatment
Population
All
Priority Level
Level 4 Three weeks (21 days)
Cite As
Badea, A; Groot, G; Mueller, M; Young, C. Are probiotics effective for prevention or therapy of respiratory tract infections in all ages? 2020 Nov 25; Document no.: EOC111201 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 13 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC040202-01 ESR
Question Submitted
April 2, 2020
Date Completed
April 2, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC040202-01 ESR
Question Submitted
April 2, 2020
Date Completed
April 2, 2020
Status
3. Completed
Research Team
EOC
Notes
No rapid review written.
Category
Infection Prevention and Control
Clinical Management
Subject
Risk
Personal Protective Equipment
Priority Level
Level 2 completed within 8 hours
Cite As
Howell-Spooner, B; Fox, L. Is it safe to perform CPR on patients with suspected or confirmed COVID-19 while using PPE? 2020 Apr 2; Document no.: EOC040202-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 13 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
PPE041702-01 ESR
Question Submitted
April 17, 2020
Date Completed
April 17, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Document Type
Evidence Search Report
Review Code
PPE041702-01 ESR
Question Submitted
April 17, 2020
Date Completed
April 17, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Notes
This was never assigned to an RR
Category
Clinical Management
Infection Prevention and Control
Subject
Aerosols
Personal Protective Equipment
Decision Making
Population
All
Priority Level
Level 2 completed within 8 hours
Cite As
Miller, L; Dalidowicz, M. What is the clinical evidence used to support aerosol generating medical procedures recommendations and guidelines regarding line flow volume or pressure? 2020 Apr 11; Document no.: PPE041702-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC042201 RR
Question Submitted
April 22, 2020
Date Completed
April 27, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC042201 RR
Question Submitted
April 22, 2020
Date Completed
April 27, 2020
Status
3. Completed
Research Team
EOC
Key Findings
Mild to moderate disease that it to be managed at home is not as well defined as severe to critical, requiring hospitalization
General consensus that the appearance of severe respiratory systems or altered consciousness are the threshold for requiring hospitalization
Most guidance for assisted monitoring is limited to LTC or other care facilities vs. home care for abled individuals
Category
Clinical Presentation
Clinical Management
Subject
Risk
Treatment
Priority Level
Level 4 completed within 1 week
Cite As
Badea, A; Groot, G; Fox, L; Miller, M. What are the classification levels for disease severity of COVID-19 and how should each level be treated? 2020 Apr 27; Document no.: EOC042201 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 10 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC051201-01 ESR
Question Submitted
May 12, 2020
Date Completed
May 13, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC051201-01 ESR
Question Submitted
May 12, 2020
Date Completed
May 13, 2020
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Clinical Management
Subject
Personal Protective Equipment
Aerosols
Priority Level
Level 3 completed within 2-3 days
Cite As
Dalidowicz, M; Miller, L. Do neck or back coverings provide additional protection to gown and N95 mask when conducting an aerosol generating procedure? 2020 May 13; Document no.: EOC051201-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 18 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC051201 RR
Question Submitted
May 12, 2020
Date Completed
May 15, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC051201 RR
Question Submitted
May 12, 2020
Date Completed
May 15, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Small simulation studies have demonstrated potential contamination of neck and back area · Many associations recommend neck coverage, or if unavailable to ensure sanitation/washing of exposed skin after doffing PPE · Several warnings that increasing amount of PPE increases chances of contamination and may decrease level of compliance
Category
Infection Prevention and Control
Clinical Management
Subject
Personal Protective Equipment
Aerosols
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Groot, G; Dalidowicz, M; Miller, L. Do neck or back coverings provide additional protection to gown and N95 mask when conducting an aerosol generating procedure? 2020 May 15; Document no.: EOC051201 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 9 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC052102-01 ESR
Question Submitted
May 21, 2020
Date Completed
May 21, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC052102-01 ESR
Question Submitted
May 21, 2020
Date Completed
May 21, 2020
Status
3. Completed
Research Team
EOC
Category
Administration
Clinical Management
Subject
Ventilation
Health Planning
Population
All
Clinical Setting
ICU
Priority Level
Level 3 completed within 2-3 days
Cite As
Miller, L; Dalidowicz, M. In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation? 2020 May 21; Document no.: EOC052102-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 19 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC052102 RR
Question Submitted
May 21, 2020
Date Completed
May 22, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC052102 RR
Question Submitted
May 21, 2020
Date Completed
May 22, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· There was no source of Canadian data (published or grey, federal or provincial) to address this question and differentiate between types of ventilation. · There are several studies available assessing the proportions seen in other countries and a lot of theoretical literature about using non-invasive ventilation (NIV) as a first-line intervention to hopefully avoid intubation and invasive mechanical ventilation (IMV), for which there is weak evidence. · Key studies include an analysis of 36 ICU patients in Wuhan in which 41.7% received NIV and 47.2% received MIV. Another large-scale study of 1,099 hospitalized patients reported IMV in 6.1% with no report of NIV.
Category
Administration
Clinical Management
Subject
Ventilation
Health Planning
Population
All
Clinical Setting
ICU
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Groot, G; Dalidowicz, M; Miller, L. In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation? 2020 May 22; Document no.: EOC052102 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 8 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC042201v2-01 ESR
Question Submitted
April 22, 2020
Date Completed
July 15, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC042201v2-01 ESR
Question Submitted
April 22, 2020
Date Completed
July 15, 2020
Status
3. Completed
Research Team
EOC
Category
Clinical Presentation
Clinical Management
Subject
Risk
Treatment
Priority Level
Level 4 completed within 1 week
Cite As
Fox, L; Miller, L. What are the classification levels for disease severity of COVID-19 and how should each level be treated? 2020 Jul 9; Document no.: EOC042201v2-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 20 p. (CEST evidence search report)
Related Documents
Documents

EOC042201v2-01 ESR

Read PDF Download PDF
Less detail

27 records – page 1 of 3.